The Research and Evaluation department based at UKHSA Porton has approximately 300 staff, performing a range of research activities, including high containment level work. The department's work covers a broad range of projects involving the development and evaluation of interventions into a range of infectious diseases e.g., SARS-CoV-2, Ebola, Zika, Crimean-Congo Haemorrhagic Fever, Q Fever, Anthrax, Plague, Melioidosis and Monkeypox. The department also has a test facility performing regulated studies in compliance with GLP, GCP and GMP.
This post is part of the Diagnostics Evaluation and Innovation (DEI) team at UKHSA Porton Down. The focus of the DEI team is to review, evaluate, develop, and implement diagnostic assays for the Rare and Imported Pathogens Laboratory (RIPL), the front-line diagnostic laboratory for the detection of the Viral Haemorrhagic Fevers (Ebola, Lassa, CCHF, Marburg), vector-borne viruses, Rickettsiae and biothreat agents including Bacillus anthracis and Francisella tularensis. The DEI team also evaluate diagnostic assays for external stakeholders and broader distribution across the healthcare network in the event of outbreaks and for incident response.
The Diagnostics, Evaluation and Innovation Team reviews, evaluates, develops, and implements diagnostic assays for use in UKHSA/NHS and locally for the Rare and Imported Pathogens Laboratory (RIPL), working with suppliers, commercial partners and academic groups.
As a Senior Scientist in the Diagnostics, Evaluation and Innovation Team you will provide scientific and technical expertise to deliver improved diagnostics for rare, emerging, difficult to diagnose and high consequence infectious disease agents. The post holder will also have line management responsibilities and provide surge capacity and work within the RIPL laboratory under the direction of qualified Biomedical scientists when needed.
The post holder will have a pivotal role in evaluating commercial assays and transitioning research/developmental assays for rare and difficult to diagnose pathogens into RIPL ensuring compliance with ISO15189:2022 standards and IVDR regulations. They will be expected to learn about the pathogen of interest, research possible diagnostic assays and investigate their utility against the clinical need. These tests may be for the detection of nucleic acids, protein antigens or patient antibodies. These tests must then be evaluated, and if suitable, validated and introduced into the RIPL workflow complete with SOPs, risk assessments, staff training and compliance documentation.
Your key responsibilities will include to:
The duties/responsibilities listed above describe the post as it is at present and is not intended to be exhaustive. The Job holder is expected to accept reasonable alterations and additional tasks of a similar level that may be necessary.
Selection process details
Essential Criteria - you will be assessed on the below 8 essential criteria, which have been selected from the Job Description Document.
Selection process details
This vacancy is using Success Profiles and will assess your Behaviours, Experience and Technical skills.
Stage 1 - Application & Sift:
You will be required to complete an application form. You will be assessed on the 8 essential criteria listed, and this will be in the form of a:
Application form(Employer/ Activity history section on the application
1000 word Statement of Suitability
This should outline how you consider your skills, experience, and knowledge, provide evidence of your suitability for the role, with reference to the essential criteria.
The Application form and Statement of Suitability will be marked together.
Please be aware that we will assess on the 8essential criteria stated on the advert rather than the full list on the job description document.
Longlisting: In the event of a large number of applications we will longlist into 3 piles of:
Meets some essential criteria
Meets no essential criteria
Piles Meets all essential criteriawill be moved through to the shortlisting stage.
Shortlisting: In the event of a large number of applications we will shortlist on:
Please do not exceed 1000 words. We will not consider any words over and above this number. If you are successful at this stage, you will progress to an interview. Unfortunately, late applications will not be considered.
Please note you will not be able to upload your CV. You must complete the application form in as much detail as possible. Please do not email us your CV.
Feedback will not be provided at this stage.
Stage 2: Interview (success profiles)
You will be invited to a (single) face to face interview. If face to face interviews are planned, in exceptional circumstances, we may be able to offer a remote interview.
Behaviours, Experience and Technical will be tested at interview.
The Behaviour's tested during the interview stage will be:
Interviews will be held week commencing 28th April. Please note, these dates are subject to change.
Once this job has closed, the job advert will no longer be available. You may want to save a copy for your records.
Location
This role is being offered as office/lab based at our Scientific Campus in Porton Down. Please note hybrid working is not available for this role.
If based at one of our scientific campuses, you will be required to have a Counter Terrorism Check security vetting check as a minimum. For meaningful National Security Vetting checks to be carried out individuals need to have lived in the UK for a sufficient period of time. You should normally have been resident in the United Kingdom for the last 3 years as the role requires Counter Terrorism Check (CTC) clearance. In exceptional circumstances UK residency less than the outlined periods may not necessarily bar you from gaining national security vetting and applicants should contact the Vacancy Holder/Recruiting Manager listed in the advert for further advice.
Eligibility Criteria
Open to all external applicants (anyone) from outside the Civil Service (including by definition internal applicants).
Security Clearance Level Requirement
Successful candidates must pass a disclosure and barring security check.